CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...
Phase 3
Birmingham, Alabama, United States and 46 other locations
in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema (also called atopic dermatitis) is a common sk...
Phase 3
Birmingham, Alabama, United States and 20 other locations
This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...
Phase 3
Birmingham, Alabama, United States and 38 other locations
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
Birmingham, Alabama, United States and 84 other locations
participants (in Part A) and participants with atopic dermatitis (eczema) (in Part B). REGN20423 is a study medicine that is only used in cl...
Phase 1
Birmingham, Alabama, United States and 6 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
Birmingham, Alabama, United States and 27 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
Birmingham, Alabama, United States and 88 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Birmingham, Alabama, United States and 95 other locations
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Phase 2
Birmingham, Alabama, United States and 36 other locations
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Phase 2
Birmingham, Alabama, United States of America and 100 other locations
Clinical trials
Research sites
Resources
Legal